Navigation Links
ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
Date:9/30/2008

SYDNEY, Australia, Sept. 30 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that a marketing application for the mucus clearing agent, Bronchitol, has been submitted to the Therapeutic Goods Administration (TGA) division of the Australian Government. If approved, Pharmaxis will be authorized to market Bronchitol in Australia for the treatment of bronchiectasis.

The application is based on a multicentre Phase 3 clinical trial involving more than 360 subjects which evaluated the safety and efficacy of Bronchitol for inhalation in subjects with bronchiectasis. All of the primary efficacy end points were positive and statistically significant, and Bronchitol was shown to be well tolerated with no serious adverse events attributed to treatment.

After being accepted for evaluation, the TGA has 255 working days to review the application lodged by Pharmaxis.

There is currently no approved medication that specifically targets mucus clearance for people suffering from bronchiectasis.

Alan Robertson, Pharmaxis chief executive officer said: "We are delighted to announce this major milestone for Pharmaxis and believe this is an important development for people living with the incurable lung condition bronchiectasis. Pharmaxis is dedicated to the development of safe and effective treatments for airway diseases, and we continue to work closely with regulatory authorities worldwide to bring Bronchitol to patients as quickly as possible."

It is estimated that more than 600,000 people in the major pharmaceutical markets suffer from bronchiectasis and Pharmaxis expects Bronchitol to be the first targeted medication for this patient group in 20 years, addressing an important medical need. In Australia, it is believed that more than 18,000 people live with bronchiectasis and over 70% are moderately or severely incapacitated by their condition.

Bronchitol is also under development
'/>"/>

SOURCE Pharmaxis Ltd
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation
2. New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients
3. New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option
4. HealthMedia and Aetna to Study Online Insomnia and Depression Interventions
5. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
6. Penn State Hershey Transplant Program Uses Assay to Monitor Cell-Mediated Immunity
7. New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery
8. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
9. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
10. Media Statement: MHA Keystone Center for Patient Safety & Quality OHRP Ruling
11. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... SAN JOSE, Calif. , June 19, 2013 ... (NYSE: BDX ), a leading global medical technology ... X-20 Cell Analyzer , the latest in its line of ... X-20 Cell Analyzer delivers high-performance multicolor analysis with the most ... (76.2 X 73.7 cm) and a height of 30" (76.2 ...
(Date:6/19/2013)... PLAINS, N.Y. , June 19, 2013  This ... supporting more than 300 research projects with one goal ... And in 2013, "Team In Training" (TNT), a flagship ... endurance sports training program, is marking its landmark 25 ... invest more than $875 million in research to discover ...
(Date:6/19/2013)... June 19, 2013 Today MedeAnalytics, a ... the next-generation of its Employer Group and ... plans to provide their employer groups an intuitive ... medical and prescription drug claims, network utilization, and ... http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer Group and ...
Breaking Medicine Technology:New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 2Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 3Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 4Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 5MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2
(Date:6/19/2013)... Amber Roberson with the Robert Weaver ... Care Health, LLC and Medcase, LLC, became certified ... new professional development course on the Patient Protection ... course for agents has been approved in all ... credits from the Missouri Department of Insurance. , ...
(Date:6/19/2013)... 2013 As Januvia lawsuit ... mount in courts throughout the U.S., Bernstein Liebhard LLP ... recently held a meeting to discuss the safety of ... According to a June 12th report from Bloomberg.com, ... of Januvia and similar drugs, following a recent study ...
(Date:6/19/2013)... The Journal of Parasitology – Although ... software, it creates questions of ethics. For scientific publications, ... already published case shows, scientific publications need clear guidelines ... Journal of Parasitology features a commentary on ... article published in the Journal of the New York ...
(Date:6/19/2013)... major international study led by researchers at The University ... ibrutinib continues to show remarkable promise for the treatment ... The most recent interim findings of the 18-center Phase ... England Journal of Medicine . Previous interim findings were ... of Hematology Annual Meeting and Exposition. , ...
(Date:6/19/2013)... study published in the June 19 online edition of ... by researchers from the University of California, San Diego ... that take place when cardiac regeneration occurs in zebrafish ... that various cell lines in the heart are more ... than previously thought. , More importantly, the research reveals ...
Breaking Medicine News(10 mins):Health News:RWI Benefits, LLC Becomes PPACA Certified 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2
... , Leading breast oncologists warn of dangers of Task ... recommendation to change breast screening is a huge step backwards," ... and president of Breastcancer.org. , (Logo: ... call for mammograms to start at age 50 and to ...
... , GREEN BAY, Wis., Nov. 17 Shopko ... e-commerce business which is accessible at www.shopko.com ... and service provider for retailers, to advance the Company,s online ... the Company,s offering of Holiday items in apparel, home, accessories, ...
... Sinai School of Medicine is one of 12 sites ... to test gene therapy treatment for Alzheimer,s disease. The ... research in the U.S. The experimental treatment utilizes ... Growth Factor (NGF), a naturally occurring protein that helps ...
... care for people with multiple chronic conditions, has received ... Improvement from the American Academy of Family Physicians (AAFP), ... Medical Economics magazine. Chad Boult, MD, MPH, MBA, ... of the Roger C. Lipitz Center for Integrated Health ...
... Howard Hughes Medical Institute (HHMI) today committed four ... training program between Rice University and the University ... unique program -- founded with a 2006 HHMI ... top-10-ranked bioengineering program and M.D. Anderson,s internationally renowned ...
... ... has successfully blended custom EDM machining and lights-out automation for greater speed and accuracy ... times are critical to optimized performance. , ... Tucker, GA (PRWEB) November 17, 2009 -- A proprietary new ...
Cached Medicine News:Health News:Lives Will Be Lost With Proposed Changes to Mammography Guidelines 2Health News:Lives Will Be Lost With Proposed Changes to Mammography Guidelines 3Health News:Lives Will Be Lost With Proposed Changes to Mammography Guidelines 4Health News:Shopko Announces Launch of e-Commerce Platform 2Health News:Mount Sinai researchers to test first gene therapy For Alzheimer's patients 2Health News:'Guided Care' receives Award for Innovation in Practice Improvement 2Health News:New funds for Rice, M.D. Anderson program 2Health News:Proprietary EDM Machining Technology Boosts Speed and Accuracy for Medical Components 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: